Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine

References

• Wild CP. The global cancer burden: necessity is the mother of prevention. Nat Rev Cancer. 2019;19(3):123–124. doi:10.1038/s41568-019-0110-3
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Ca a Cancer J Clinicians. 2023;73(1):17–48. doi:10.3322/caac.21763
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–436. doi:10.3322/caac.21731
   PubMed Web of Science ®Google Scholar
• Zhang QY, Wang FX, Jia KK, Kong LD. Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects. Front Pharmacol. 2018;9:1253. doi:10.3389/fphar.2018.01253
   PubMed Web of Science ®Google Scholar
• Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov. 2013;12(7):526–542. doi:10.1038/nrd4003
   PubMed Web of Science ®Google Scholar
• Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol. 2020;15(4):313–320. doi:10.1038/s41565-020-0669-6
   PubMed Web of Science ®Google Scholar
• Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70(2):86–104. doi:10.3322/caac.21596
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li M, Gao X, Chen Y, Liu T. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol. 2019;12(1):137. doi:10.1186/s13045-019-0833-3
   PubMed Web of Science ®Google Scholar
• Dessale M, Mengistu G, Mengist HM. Nanotechnology: a Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis. Int J Nanomed. 2022;17:3735–3749. doi:10.2147/ijn.S378074
   PubMed Web of Science ®Google Scholar
• Ghanbari-Movahed M, Mondal A, Farzaei MH, Bishayee A. Quercetin- and rutin-based nano-formulations for cancer treatment: a systematic review of improved efficacy and molecular mechanisms. Phytomedicine. 2022;97:153909. doi:10.1016/j.phymed.2021.153909
   PubMed Web of Science ®Google Scholar
• Kim B, Park JE, Im E, et al. Recent Advances in Nanotechnology with Nano-Phytochemicals: molecular Mechanisms and Clinical Implications in Cancer Progression. Int J Mol Sci. 2021;22(7):3571. doi:10.3390/ijms22073571
   PubMed Web of Science ®Google Scholar
• Joshi S, Durden DL. Combinatorial Approach to Improve Cancer Immunotherapy: rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System. J Oncol. 2019;2019:5245034. doi:10.1155/2019/5245034
   PubMed Web of Science ®Google Scholar
• Zhang H, Qin C, An C, et al. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer. Mol Cancer. 2021;20(1):126. doi:10.1186/s12943-021-01431-6
   PubMed Web of Science ®Google Scholar
• Wei Z, Chen J, Zuo F, et al. Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: a review. J Ethnopharmacol. 2023;300:115748. doi:10.1016/j.jep.2022.115748
   PubMed Web of Science ®Google Scholar
• Wang X, Li J, Chen R, Li T, Chen M. Active Ingredients from Chinese Medicine for Combination Cancer Therapy. Int J Biol Sci. 2023;19(11):3499–3525. doi:10.7150/ijbs.77720
   PubMed Web of Science ®Google Scholar
• Wang S, Long S, Deng Z, Wu W. Positive Role of Chinese Herbal Medicine in Cancer Immune Regulation. Am J Chin Med. 2020;48(7):1577–1592. doi:10.1142/s0192415x20500780
   PubMed Web of Science ®Google Scholar
• Peng F, Xie X, Peng C. Chinese Herbal Medicine-Based Cancer Therapy: novel Anticancer Agents Targeting MicroRNAs to Regulate Tumor Growth and Metastasis. Am J Chin Med. 2019;47(8):1711–1735. doi:10.1142/s0192415x19500873
   PubMed Web of Science ®Google Scholar
• Yan Q, Zhang Y, Wang Q, Yuan L. Autophagy: a Double-Edged Sword in Male Reproduction. Int J Mol Sci. 2022;23(23):15273. doi:10.3390/ijms232315273
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Petroni G, Amaravadi RK, et al. Autophagy in major human diseases. EMBO j. 2021;40(19):e108863. doi:10.15252/embj.2021108863
   PubMed Web of Science ®Google Scholar
• White E. The role for autophagy in cancer. J Clin Invest. 2015;125(1):42–46. doi:10.1172/jci73941
   PubMed Web of Science ®Google Scholar
• Choi KS. Autophagy and cancer. Exp Mol Med. 2012;44(2):109–120. doi:10.3858/emm.2012.44.2.033
   PubMed Web of Science ®Google Scholar
• Wang ZY, Liu J, Zhu Z, et al. Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: a mechanism review. Biomed Pharmacother. 2021;133:110968. doi:10.1016/j.biopha.2020.110968
   PubMed Web of Science ®Google Scholar
• Shi X, Chang M, Zhao M, Shi Y, Zhang Y. Traditional Chinese medicine compounds ameliorating glomerular diseases via autophagy: a mechanism review. Biomed Pharmacother. 2022;156:113916. doi:10.1016/j.biopha.2022.113916
   PubMed Web of Science ®Google Scholar
• Cui B, Yu JM. Autophagy: a new pathway for traditional Chinese medicine. J Asian Nat Prod Res. 2018;20(1):14–26. doi:10.1080/10286020.2017.1374948
   PubMed Web of Science ®Google Scholar
• Zhao W, Zheng XD, Tang PY, et al. Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi-active components combination. Med Res Rev. 2023;43(5):1778–1808. doi:10.1002/med.21963
   PubMed Web of Science ®Google Scholar
• Dehelean CA, Marcovici I, Soica C, et al. Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules. 2021;26(4):1109. doi:10.3390/molecules26041109
   PubMed Web of Science ®Google Scholar
• Yousefi M, Narmani A, Jafari SM. Dendrimers as efficient nanocarriers for the protection and delivery of bioactive phytochemicals. Adv Colloid Interface Sci. 2020;278:102125. doi:10.1016/j.cis.2020.102125
   PubMed Web of Science ®Google Scholar
• Avula LR, Grodzinski P. Nanotechnology-aided advancement in the combating of cancer metastasis. Cancer Metastasis Rev. 2022;41(2):383–404. doi:10.1007/s10555-022-10025-7
   PubMed Web of Science ®Google Scholar
• Singh A, Amiji MM. Application of nanotechnology in medical diagnosis and imaging. Curr Opin Biotechnol. 2022;74:241–246. doi:10.1016/j.copbio.2021.12.011
   PubMed Web of Science ®Google Scholar
• Nasir A, Khan A, Li J, et al. Nanotechnology, A Tool for Diagnostics and Treatment of Cancer. Curr Top Med Chem. 2021;21(15):1360–1376. doi:10.2174/1568026621666210701144124
   PubMed Web of Science ®Google Scholar
• Liu XL, Dong X, Yang SC, et al. Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy. Adv Sci (Weinh). 2021;8(8):2003679. doi:10.1002/advs.202003679
   PubMedGoogle Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16(1):71. doi:10.1186/s12951-018-0392-8
   PubMed Web of Science ®Google Scholar
• Fu S, Li G, Zang W, Zhou X, Shi K, Zhai Y. Pure drug nano-assemblies: a facile carrier-free nanoplatform for efficient cancer therapy. Acta Pharm Sin B. 2022;12(1):92–106. doi:10.1016/j.apsb.2021.08.012
   PubMed Web of Science ®Google Scholar
• Hu T, Qin Z, Shen C, Gong HL, He ZY. Multifunctional Mitochondria-Targeting Nanosystems for Enhanced Anticancer Efficacy. Front Bioeng Biotechnol. 2021;9:786621. doi:10.3389/fbioe.2021.786621
   PubMed Web of Science ®Google Scholar
• Wathoni N, Rusdin A, Motoyama K, Joni IM, Lesmana R, Muchtaridi M. Nanoparticle Drug Delivery Systems for α-Mangostin. Nanotechnol Sci Appl. 2020;13:23–36. doi:10.2147/nsa.S243017
   PubMed Web of Science ®Google Scholar
• Wu K, Yu B, Li D, Tian Y, Liu Y, Jiang J. Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma. Front Oncol. 2022;12:805978. doi:10.3389/fonc.2022.805978
   PubMed Web of Science ®Google Scholar
• Jampilek J, Kralova K. Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems. Pharmaceutics. 2022;14(12):2681. doi:10.3390/pharmaceutics14122681
   PubMed Web of Science ®Google Scholar
• Wahi A, Bishnoi M, Raina N, et al. Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment. Oncol Res. 2023;32(1):19–47. doi:10.32604/or.2023.042228
   PubMed Web of Science ®Google Scholar
• Kumari S, Goyal A, Sönmez Gürer E, et al. Bioactive Loaded Novel Nano-Formulations for Targeted Drug Delivery and Their Therapeutic Potential. Pharmaceutics. 2022;14(5):1091. doi:10.3390/pharmaceutics14051091
   PubMed Web of Science ®Google Scholar
• Yang X, Zhao M, Wu Z, et al. Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy. ACS Nano. 2022;16(2):3417–3431. doi:10.1021/acsnano.2c00462
   PubMed Web of Science ®Google Scholar
• Björnmalm M, Thurecht KJ, Michael M, Scott AM, Caruso F. Bridging Bio-Nano Science and Cancer Nanomedicine. ACS Nano. 2017;11(10):9594–9613. doi:10.1021/acsnano.7b04855
   PubMed Web of Science ®Google Scholar
• Fang J, Islam W, Maeda H. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers. Adv Drug Deliv Rev. 2020;157:142–160. doi:10.1016/j.addr.2020.06.005
   PubMed Web of Science ®Google Scholar
• Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol. 2021;14(1):85. doi:10.1186/s13045-021-01096-0
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014;53(46):12320–12364. doi:10.1002/anie.201403036
   PubMed Web of Science ®Google Scholar
• Lian B, Wu M, Feng Z, Deng Y, Zhong C, Zhao X. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors. Artif Cells Nanomed Biotechnol. 2019;47(1):154–165. doi:10.1080/21691401.2018.1548468
   PubMed Web of Science ®Google Scholar
• Fu X, Shi Y, Qi T, et al. Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting. Signal Transduct Target Ther. 2020;5(1):262. doi:10.1038/s41392-020-00342-0
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhang T, Ma X, et al. Microenvironment-Responsive Prodrug-Induced Pyroptosis Boosts Cancer Immunotherapy. Adv Sci (Weinh). 2021;8(24):e2101840. doi:10.1002/advs.202101840
   PubMedGoogle Scholar
• Lu CH, Willner I. Stimuli-responsive DNA-functionalized nano-/microcontainers for switchable and controlled release. Angew Chem Int Ed Engl. 2015;54(42):12212–12235. doi:10.1002/anie.201503054
   PubMed Web of Science ®Google Scholar
• Price R, Poursaid A, Ghandehari H. Controlled release from recombinant polymers. J Control Release. 2014;190:304–313. doi:10.1016/j.jconrel.2014.06.016
   PubMed Web of Science ®Google Scholar
• Cheng X, Xu HD, Ran HH, Liang G, Wu FG. Glutathione-Depleting Nanomedicines for Synergistic Cancer Therapy. ACS Nano. 2021;15(5):8039–8068. doi:10.1021/acsnano.1c00498
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Kumar A, et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014;32(4):693–710. doi:10.1016/j.biotechadv.2013.11.009
   PubMed Web of Science ®Google Scholar
• Duan J, Li Y, Gao J, Cao R, Shang E, Zhang W. ROS-mediated photoaging pathways of nano- and micro-plastic particles under UV irradiation. Water Res. 2022;216:118320. doi:10.1016/j.watres.2022.118320
   PubMed Web of Science ®Google Scholar
• Hameed S, Zhang M, Bhattarai P, Mustafa G, Dai Z. Enhancing cancer therapeutic efficacy through ultrasound-mediated micro-to-nano conversion. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12(3):e1604. doi:10.1002/wnan.1604
   PubMed Web of Science ®Google Scholar
• Zhu R, He Q, Li Z, et al. ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy. Acta Biomater. 2022;153:442–452. doi:10.1016/j.actbio.2022.09.061
   PubMed Web of Science ®Google Scholar
• Staffa SJ, Kohane DS, Zurakowski D. Synergy in Nanomedicine: what It Is Not, and What It Might Be. Nano Lett. 2021;21(13):5457–5460. doi:10.1021/acs.nanolett.1c01894
   PubMed Web of Science ®Google Scholar
• Bar-Zeev M, Livney YD, Assaraf YG. Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance. Drug Resist Updat. 2017;31:15–30. doi:10.1016/j.drup.2017.05.002
   PubMed Web of Science ®Google Scholar
• Li J, Cai W, Yu J, et al. Autophagy inhibition recovers deficient ICD-based cancer immunotherapy. Biomaterials. 2022;287:121651. doi:10.1016/j.biomaterials.2022.121651
   PubMed Web of Science ®Google Scholar
• Menon JU, Jadeja P, Tambe P, Vu K, Yuan B, Nguyen KT. Nanomaterials for photo-based diagnostic and therapeutic applications. Theranostics. 2013;3(3):152–166. doi:10.7150/thno.5327
   PubMed Web of Science ®Google Scholar
• Pan WL, Tan Y, Meng W, et al. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework. Biomaterials. 2022;283:121449. doi:10.1016/j.biomaterials.2022.121449
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhao P, Luo Z, et al. Cancer Cell Membrane-Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy. ACS Nano. 2016;10(11):10049–10057. doi:10.1021/acsnano.6b04695
   PubMed Web of Science ®Google Scholar
• Kozma GT, Shimizu T, Ishida T, Szebeni J. Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Adv Drug Deliv Rev. 2020;154-155:163–175. doi:10.1016/j.addr.2020.07.024
   PubMed Web of Science ®Google Scholar
• Guo S, Shi Y, Liang Y, Liu L, Sun K, Li Y. Relationship and improvement strategies between drug nanocarrier characteristics and hemocompatibility: what can we learn from the literature. Asian J Pharm Sci. 2021;16(5):551–576. doi:10.1016/j.ajps.2020.12.002
   PubMed Web of Science ®Google Scholar
• Wang B, He X, Zhang Z, Zhao Y, Feng W. Metabolism of nanomaterials in vivo: blood circulation and organ clearance. Acc Chem Res. 2013;46(3):761–769. doi:10.1021/ar2003336
   PubMed Web of Science ®Google Scholar
• Villeret B, Dieu A, Straube M, et al. Silver Nanoparticles Impair Retinoic Acid-Inducible Gene I-Mediated Mitochondrial Antiviral Immunity by Blocking the Autophagic Flux in Lung Epithelial Cells. ACS Nano. 2018;12(2):1188–1202. doi:10.1021/acsnano.7b06934
   PubMed Web of Science ®Google Scholar
• Wan HY, Chen JL, Zhu X, Liu L, Wang J, Zhu XM. Titania-Coated Gold Nano-Bipyramids for Blocking Autophagy Flux and Sensitizing Cancer Cells to Proteasome Inhibitor-Induced Death. Adv Sci (Weinh). 2018;5(3):1700585. doi:10.1002/advs.201700585
   PubMedGoogle Scholar
• Xu Q, Zhang H, Liu H, Han Y, Qiu W, Li Z. Inhibiting autophagy flux and DNA repair of tumor cells to boost radiotherapy of orthotopic glioblastoma. Biomaterials. 2022;280:121287. doi:10.1016/j.biomaterials.2021.121287
   PubMed Web of Science ®Google Scholar
• Ruan S, Xie R, Qin L, et al. Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment. Nano Lett. 2019;19(11):8318–8332. doi:10.1021/acs.nanolett.9b03968
   PubMed Web of Science ®Google Scholar
• De Dosso S, Siebenhüner AR, Winder T, et al. Treatment landscape of metastatic pancreatic cancer. Cancer Treat Rev. 2021;96:102180. doi:10.1016/j.ctrv.2021.102180
   PubMed Web of Science ®Google Scholar
• Yardley DA. nab-Paclitaxel mechanisms of action and delivery. J Control Release. 2013;170(3):365–372. doi:10.1016/j.jconrel.2013.05.041
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Doxil®--The first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117–134. doi:10.1016/j.jconrel.2012.03.020
   PubMed Web of Science ®Google Scholar
• Hulst MB, Grocholski T, Neefjes JJC, van Wezel GP, Metsä-Ketelä M. Anthracyclines: biosynthesis, engineering and clinical applications. Nat Prod Rep. 2022;39(4):814–841. doi:10.1039/d1np00059d
   PubMed Web of Science ®Google Scholar
• Pujade-Lauraine E, Fujiwara K, Ledermann JA, et al. Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, Phase 3 study. Lancet Oncol. 2021;22(7):1034–1046. doi:10.1016/s1470-2045(21)00216-3
   PubMed Web of Science ®Google Scholar
• Emens LA, Adams S, Barrios CH, et al. First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: iMpassion130 final overall survival analysis. Ann Oncol. 2021;32(8):983–993. doi:10.1016/j.annonc.2021.05.355
   PubMed Web of Science ®Google Scholar
• Zou L, Liao M, Zhen Y, et al. Autophagy and beyond: unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications. Acta Pharm Sin B. 2022;12(10):3743–3782. doi:10.1016/j.apsb.2022.06.004
   PubMed Web of Science ®Google Scholar
• Grunwald DS, Otto NM, Park JM, Song D, Kim DH. GABARAPs and LC3s have opposite roles in regulating ULK1 for autophagy induction. Autophagy. 2020;16(4):600–614. doi:10.1080/15548627.2019.1632620
   PubMed Web of Science ®Google Scholar
• Tanida I. Autophagy basics. Microbiol Immunol. 2011;55(1):1–11. doi:10.1111/j.1348-0421.2010.00271.x
   PubMed Web of Science ®Google Scholar
• Frudd K, Burgoyne T, Burgoyne JR. Oxidation of Atg3 and Atg7 mediates inhibition of autophagy. Nat Commun. 2018;9(1):95. doi:10.1038/s41467-017-02352-z
   PubMedGoogle Scholar
• Kaiser SE, Mao K, Taherbhoy AM, et al. Noncanonical E2 recruitment by the autophagy E1 revealed by Atg7-Atg3 and Atg7-Atg10 structures. Nat Struct Mol Biol. 2012;19(12):1242–1249. doi:10.1038/nsmb.2415
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Komatsu M. Selective degradation of p62 by autophagy. Semin Immunopathol. 2010;32(4):431–436. doi:10.1007/s00281-010-0220-1
   PubMed Web of Science ®Google Scholar
• Sui X, Chen R, Wang Z, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4(10):e838. doi:10.1038/cddis.2013.350
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Gao J, Wen L. Pro-Death or Pro-Survival: contrasting Paradigms on Nanomaterial-Induced Autophagy and Exploitations for Cancer Therapy. Acc Chem Res. 2019;52(11):3164–3176. doi:10.1021/acs.accounts.9b00397
   PubMed Web of Science ®Google Scholar
• Usman RM, Razzaq F, Akbar A, et al. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance. Asia Pac J Clin Oncol. 2021;17(3):193–208. doi:10.1111/ajco.13449
   PubMed Web of Science ®Google Scholar
• Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death. Cell Death Dis. 2023;14(10):648. doi:10.1038/s41419-023-06154-8
   PubMed Web of Science ®Google Scholar
• Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19(1):12. doi:10.1186/s12943-020-1138-4
   PubMed Web of Science ®Google Scholar
• Towers CG, Wodetzki D, Thorburn A. Autophagy and cancer: modulation of cell death pathways and cancer cell adaptations. J Cell Biol. 2020;219(1):33. doi:10.1083/jcb.201909033
   Web of Science ®Google Scholar
• Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N. Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta. 2013;1833(12):3448–3459. doi:10.1016/j.bbamcr.2013.06.001
   PubMed Web of Science ®Google Scholar
• Saleem S. Apoptosis, Autophagy, Necrosis and Their Multi Galore Crosstalk in Neurodegeneration. Neuroscience. 2021;469:162–174. doi:10.1016/j.neuroscience.2021.06.023
   PubMed Web of Science ®Google Scholar
• Wu J, Ye J, Xie Q, Liu B, Liu M. Targeting Regulated Cell Death with Pharmacological Small Molecules: an Update on Autophagy-Dependent Cell Death, Ferroptosis, and Necroptosis in Cancer. J Med Chem. 2022;65(4):2989–3001. doi:10.1021/acs.jmedchem.1c01572
   PubMed Web of Science ®Google Scholar
• Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196. doi:10.1038/s41392-022-01046-3
   PubMed Web of Science ®Google Scholar
• He C, Bassik MC, Moresi V, et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature. 2012;481(7382):511–515. doi:10.1038/nature10758
   PubMed Web of Science ®Google Scholar
• Wu W, Wang X, Sun Y, et al. TNF-induced necroptosis initiates early autophagy events via RIPK3-dependent AMPK activation, but inhibits late autophagy. Autophagy. 2021;17(12):3992–4009. doi:10.1080/15548627.2021.1899667
   PubMed Web of Science ®Google Scholar
• Liu X, Liu L, Wang X, et al. Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer. Phytomedicine. 2023;118:154943. doi:10.1016/j.phymed.2023.154943
   PubMed Web of Science ®Google Scholar
• Lee S, Hwang N, Seok BG, Lee S, Lee SJ, Chung SW. Autophagy mediates an amplification loop during ferroptosis. Cell Death Dis. 2023;14(7):464. doi:10.1038/s41419-023-05978-8
   PubMed Web of Science ®Google Scholar
• Barman R, Bora PK, Saikia J, et al. Nutmegs and wild nutmegs: an update on ethnomedicines, phytochemicals, pharmacology, and toxicity of the Myristicaceae species. Phytother Res. 2021;35(9):4632–4659. doi:10.1002/ptr.7098
   PubMed Web of Science ®Google Scholar
• Qin R, You FM, Zhao Q, et al. Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. J Hematol Oncol. 2022;15(1):133. doi:10.1186/s13045-022-01350-z
   PubMed Web of Science ®Google Scholar
• Khan H, Ullah H, Martorell M, et al. Flavonoids nanoparticles in cancer: treatment, prevention and clinical prospects. Semin Cancer Biol. 2021;69:200–211. doi:10.1016/j.semcancer.2019.07.023
   PubMed Web of Science ®Google Scholar
• Küpeli Akkol E, Genç Y, Karpuz B, Sobarzo-Sánchez E, Capasso R. Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer. Cancers (Basel). 2020;12(7):1959doi. doi:10.3390/cancers12071959
   Web of Science ®Google Scholar
• Jang WY, Kim MY, Cho JY. Antioxidant, Anti-Inflammatory, Anti-Menopausal, and Anti-Cancer Effects of Lignans and Their Metabolites. Int J Mol Sci. 2022;23(24):15482. doi:10.3390/ijms232415482
   PubMed Web of Science ®Google Scholar
• Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560–575. doi:10.1038/s41580-023-00585-z
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542. doi:10.1038/nrc.2017.53
   PubMed Web of Science ®Google Scholar
• Fan L, Wu L, Yu XH, Chen YB, Lin L, Li SG. The ethnopharmacology, phytochemistry, pharmacology and toxicology of the genus Erycibe (Convolvulaceae). J Ethnopharmacol. 2021;278:114312. doi:10.1016/j.jep.2021.114312
   PubMed Web of Science ®Google Scholar
• Tu YJ, Fan X, Yang X, Zhang C, Liang HP. Evodiamine activates autophagy as a cytoprotective response in murine Lewis lung carcinoma cells. Oncol Rep. 2013;29(2):481–490. doi:10.3892/or.2012.2125
   PubMed Web of Science ®Google Scholar
• Hong Z, Wang Z, Zhou B, et al. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells. Int J Oncol. 2020;56(3):783–793. doi:10.3892/ijo.2020.4956
   PubMed Web of Science ®Google Scholar
• Liu AJ, Wang SH, Chen KC, et al. Evodiamine, a plant alkaloid, induces calcium/JNK-mediated autophagy and calcium/mitochondria-mediated apoptosis in human glioblastoma cells. Chem Biol Interact. 2013;205(1):20–28. doi:10.1016/j.cbi.2013.06.004
   PubMed Web of Science ®Google Scholar
• Rasul A, Yu B, Zhong L, Khan M, Yang H, Ma T. Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy. Oncol Rep. 2012;27(5):1481–1487. doi:10.3892/or.2012.1694
   PubMed Web of Science ®Google Scholar
• Liu XM, Li Z, Xie XR, et al. Combination of DNA Damage, Autophagy, and ERK Inhibition: novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity. J Med Chem. 2023;66(3):1852–1872. doi:10.1021/acs.jmedchem.2c01660
   PubMedGoogle Scholar
• Jiang S, Chang H, Deng S, Fan D. Icariin enhances the chemosensitivity of cisplatin resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway. Int J Oncol. 2019;54(6):1933–1942. doi:10.3892/ijo.2019.4785
   PubMed Web of Science ®Google Scholar
• Cheng X, Tan S, Duan F, Yuan Q, Li Q, Deng G. Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM. Breast Cancer. 2019;26(6):766–775. doi:10.1007/s12282-019-00980-5
   PubMed Web of Science ®Google Scholar
• Xu W, Ding J, Li B, et al. Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7/m-TOR/SREBP1 pathway on prostate cancer. Biofactors. 2023;49(2):438–456. doi:10.1002/biof.1927
   PubMed Web of Science ®Google Scholar
• Çetinkaya M, Baran Y. Therapeutic Potential of Luteolin on Cancer. Vaccines. 2023;11(3):554. doi:10.3390/vaccines11030554
   Web of Science ®Google Scholar
• Imran M, Rauf A, Abu-Izneid T, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612. doi:10.1016/j.biopha.2019.108612
   PubMed Web of Science ®Google Scholar
• Cao Z, Zhang H, Cai X, et al. Luteolin Promotes Cell Apoptosis by Inducing Autophagy in Hepatocellular Carcinoma. Cell Physiol Biochem. 2017;43(5):1803–1812. doi:10.1159/000484066
   PubMedGoogle Scholar
• Monti E, Marras E, Prini P, Gariboldi MB. Luteolin impairs hypoxia adaptation and progression in human breast and colon cancer cells. Eur J Pharmacol. 2020;881:173210. doi:10.1016/j.ejphar.2020.173210
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhu D, Hao B, Zhang Z, Tian Y. Luteolin promotes the sensitivity of cisplatin in ovarian cancer by decreasing PRPA1-medicated autophagy. Cell Mol Biol (Noisy-le-Grand). 2018;64(6):17–22.
   PubMed Web of Science ®Google Scholar
• Wu L, Lin Y, Gao S, et al. Luteolin inhibits triple-negative breast cancer by inducing apoptosis and autophagy through SGK1-FOXO3a-BNIP3 signaling. Front Pharmacol. 2023;14:1200843. doi:10.3389/fphar.2023.1200843
   PubMed Web of Science ®Google Scholar
• Ferrari E, Bettuzzi S, Naponelli V. The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: a Narrative Review. Int J Mol Sci. 2022;23(11):6075. doi:10.3390/ijms23116075
   PubMed Web of Science ®Google Scholar
• Senggunprai L, Kukongviriyapan V, Prawan A, Kukongviriyapan U. Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway. Phytother Res. 2014;28(6):841–848. doi:10.1002/ptr.5061
   PubMed Web of Science ®Google Scholar
• Yuan CH, Horng CT, Lee CF, et al. Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling. Environ Toxicol: Int J. 2017;32(3):845–855. doi:10.1002/tox.22284
   PubMed Web of Science ®Google Scholar
• Zhao L, Liu S, Xu J, et al. A new molecular mechanism underlying the EGCG-mediated autophagic modulation of AFP in HepG2 cells. Cell Death Dis. 2017;8(11):e3160. doi:10.1038/cddis.2017.563
   PubMedGoogle Scholar
• Meng J, Chang C, Chen Y, Bi F, Ji C, Liu W. EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC. Onco Targets Ther. 2019;12:6033–6043. doi:10.2147/ott.S209441
   PubMed Web of Science ®Google Scholar
• Alam M, Rashid S, Fatima K, et al. Biochemical features and therapeutic potential of α-Mangostin: mechanism of action, medicinal values, and health benefits. Biomed Pharmacother. 2023;163:114710. doi:10.1016/j.biopha.2023.114710
   PubMed Web of Science ®Google Scholar
• Kim SM, Han JM, Le TT, Sohng JK, Jung HJ. Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α. Int J Mol Sci. 2020;21(11):4043. doi:10.3390/ijms21114043
   PubMed Web of Science ®Google Scholar
• Huang W, Liang Y, Ma X. Alpha-mangostin induces endoplasmic reticulum stress and autophagy which count against fatty acid synthase inhibition mediated apoptosis in human breast cancer cells. Cancer Cell Int. 2019;19:151. doi:10.1186/s12935-019-0869-z
   PubMed Web of Science ®Google Scholar
• Wang F, Ma H, Liu Z, Huang W, Xu X, Zhang X. α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice. Biomed Pharmacother. 2017;92:672–680. doi:10.1016/j.biopha.2017.05.129
   PubMed Web of Science ®Google Scholar
• Chao AC, Hsu YL, Liu CK, Kuo PL. α-Mangostin, a dietary xanthone, induces autophagic cell death by activating the AMP-activated protein kinase pathway in glioblastoma cells. J Agric Food Chem. 2011;59(5):2086–2096. doi:10.1021/jf1042757
   PubMed Web of Science ®Google Scholar
• Li RR, Zeng DY. The effects and mechanism of α-mangostin on chemosensitivity of gastric cancer cells. Kaohsiung J Med Sci. 2021;37(8):709–717. doi:10.1002/kjm2.12388
   PubMed Web of Science ®Google Scholar
• Xin Z, Haoran H, ZHenyi Z, Liyang Y, Pingping F, Zengjiang Y. Effect of Shikonin on autophagy and apoptosis of human gastric cancer MGC803 cells by regulating PI3K/Akt/mTOR. China CurrAdv Gen Surg. 2023;26(07):511–515.
   Google Scholar
• Xin Z, Haoran H, Ruifeng Q. Shikonin Reverses Oxaliplatin Resistance of Human Gastric Cancer Cells by lnhibiting Pl3K/Akt/mTOR Pathway. J RES MED SCI. 2023;52(06):127–131+35.
   Google Scholar
• Kun F, Fang Q, Yani D. Effects of Shikonin on Ovarian Cancer SK-OV-3 Cells Through Autophagy Mediated by Keap1/Nrf2 Signaling Pathway. Tradit Chin Drug Res Pharmacol. 2023;34(08):1053–1060. doi:10.19378/j.issn.1003-9783.2023.08.005
   Google Scholar
• Zhang J, Shang L, Jiang W, Wu W. Shikonin induces apoptosis and autophagy via downregulation of pyrroline-5-carboxylate reductase1 in hepatocellular carcinoma cells. Bioengineered. 2022;13(3):7904–7918. doi:10.1080/21655979.2022.2052673
   PubMed Web of Science ®Google Scholar
• Zhang N, Peng F, Wang Y, et al. Shikonin induces colorectal carcinoma cells apoptosis and autophagy by targeting galectin-1/JNK signaling axis. Int J Biol Sci. 2020;16(1):147–161. doi:10.7150/ijbs.36955
   PubMed Web of Science ®Google Scholar
• Liu Y, Kang X, Niu G, et al. Shikonin induces apoptosis and prosurvival autophagy in human melanoma A375 cells via ROS-mediated ER stress and p38 pathways. Artif Cells Nanomed Biotechnol. 2019;47(1):626–635. doi:10.1080/21691401.2019.1575229
   PubMed Web of Science ®Google Scholar
• Zheng Q, Li Q, Zhao G, et al. Alkannin induces cytotoxic autophagy and apoptosis by promoting ROS-mediated mitochondrial dysfunction and activation of JNK pathway. Biochem Pharmacol. 2020;180:114167. doi:10.1016/j.bcp.2020.114167
   PubMed Web of Science ®Google Scholar
• Ju X, Zhang H, Wang J, Sun Z, Guo L, Wang Q. Shikonin triggers GSDME-mediated pyroptosis in tumours by regulating autophagy via the ROS-MAPK14/p38α axis. Phytomedicine. 2023;109:154596. doi:10.1016/j.phymed.2022.154596
   PubMed Web of Science ®Google Scholar
• Kim HJ, Hwang KE, Park DS, et al. Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells. J Transl Med. 2017;15(1):123. doi:10.1186/s12967-017-1223-7
   PubMedGoogle Scholar
• Min LUO, Ping MIU, Ai-xiang WU, Zhong-yi SHAO, Hua YANG. Honokiol induces autophagy by inhibiting mTOR signaling pathway in lung cancer A549 cells. Chin J Pathophysiol. 2019;35(07):1195–1198.
   Google Scholar
• Huang K, Chen Y, Zhang R, et al. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis. 2018;9(2):157. doi:10.1038/s41419-017-0166-5
   PubMedGoogle Scholar
• Yeh PS, Wang W, Chang YA, Lin CJ, Wang JJ, Chen RM. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration. Cancer Lett. 2016;370(1):66–77. doi:10.1016/j.canlet.2015.08.030
   PubMed Web of Science ®Google Scholar
• Xu T, Tian W, Zhang Q, et al. Novel 1,3,4-thiadiazole/oxadiazole-linked honokiol derivatives suppress cancer via inducing PI3K/Akt/mTOR-dependent autophagy. Bioorg Chem. 2021;115:105257. doi:10.1016/j.bioorg.2021.105257
   PubMed Web of Science ®Google Scholar
• Hong P, Liu QW, Xie Y, et al. Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis. Cell Death Dis. 2020;11(7):524. doi:10.1038/s41419-020-2730-7
   PubMed Web of Science ®Google Scholar
• Zhou J, Jiang YY, Chen H, Wu YC, Zhang L. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Cell Prolif. 2020;53(2):e12739. doi:10.1111/cpr.12739
   PubMed Web of Science ®Google Scholar
• El-Baba C, Baassiri A, Kiriako G, et al. Terpenoids’ anti-cancer effects: focus on autophagy. Apoptosis. 2021;26(9–10):491–511. doi:10.1007/s10495-021-01684-y
   PubMed Web of Science ®Google Scholar
• Li J, Fan Y, Zhang Y, Liu Y, Yu Y, Ma M. Resveratrol Induces Autophagy and Apoptosis in Non-Small-Cell Lung Cancer Cells by Activating the NGFR-AMPK-mTOR Pathway. Nutrients. 2022;14(12):22413. doi:10.3390/nu14122413
   Web of Science ®Google Scholar
• Cao S, Wang C, Yan J, Li X, Wen J, Hu C. Curcumin ameliorates oxidative stress-induced intestinal barrier injury and mitochondrial damage by promoting Parkin dependent mitophagy through AMPK-TFEB signal pathway. Free Radic Biol Med. 2020;147:8–22. doi:10.1016/j.freeradbiomed.2019.12.004
   PubMed Web of Science ®Google Scholar
• Shrivastava N, Parikh A, Dewangan RP, et al. Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer. Pharmaceutics. 2022;14(7):1486. doi:10.3390/pharmaceutics14071486
   PubMed Web of Science ®Google Scholar
• Yu Z, Guo J, Hu M, Gao Y, Huang L. Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma. ACS Nano. 2020;14(4):4816–4828. doi:10.1021/acsnano.0c00708
   PubMed Web of Science ®Google Scholar
• Guo J, Zeng H, Liu Y, et al. Multicomponent thermosensitive lipid complexes enhance desmoplastic tumor therapy through boosting anti-angiogenesis and synergistic strategy. Int J Pharm. 2021;601:120533. doi:10.1016/j.ijpharm.2021.120533
   PubMedGoogle Scholar
• Wu C, Xu Q, Chen X, Liu J. Delivery luteolin with folacin-modified nanoparticle for glioma therapy. Int J Nanomed. 2019;14:7515–7531. doi:10.2147/ijn.S214585
   PubMed Web of Science ®Google Scholar
• Jhaveri A, Deshpande P, Pattni B, Torchilin V. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. J Control Release. 2018;277:89–101. doi:10.1016/j.jconrel.2018.03.006
   PubMed Web of Science ®Google Scholar
• Chandra Boinpelly V, Verma RK, Srivastav S, Srivastava RK, Shankar S. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway. J Cell Mol Med. 2020;24(19):11343–11354. doi:10.1111/jcmm.15731
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ji Y, Hu N, et al. Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment. Asian J Pharm Sci. 2022;17(5):751–766. doi:10.1016/j.ajps.2022.07.006
   PubMed Web of Science ®Google Scholar
• Ma BL, Ma YM. Pharmacokinetic herb-drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research. Drug Metab Rev. 2016;48(1):1–26. doi:10.3109/03602532.2015.1124888
   PubMed Web of Science ®Google Scholar
• Wei D, Yang H, Zhang Y, et al. Nano-traditional Chinese medicine: a promising strategy and its recent advances. J Mater Chem B. 2022;10(16):2973–2994. doi:10.1039/d2tb00225f
   PubMedGoogle Scholar
• Wang M, Chen L, Liu D, Chen H, Tang DD, Zhao YY. Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine. Chem Biol Interact. 2017;273:133–141. doi:10.1016/j.cbi.2017.06.011
   PubMed Web of Science ®Google Scholar
• Sithole MN, Marais S, Maree SM, Du Plessis LH, Du Plessis J, Gerber M. Development and characterization of nano-emulsions and nano-emulgels for transdermal delivery of statins. Expert Opin Drug Deliv. 2021;18(6):789–801. doi:10.1080/17425247.2021.1867533
   PubMed Web of Science ®Google Scholar
• Wang Y, Li S, Wang X, et al. Smart transformable nanomedicines for cancer therapy. Biomaterials. 2021;271:120737. doi:10.1016/j.biomaterials.2021.120737
   PubMed Web of Science ®Google Scholar
• Solanki R, Rostamabadi H, Patel S, Jafari SM. Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: a critical review. Int J Biol Macromol. 2021;193(Pt A):528–540. doi:10.1016/j.ijbiomac.2021.10.040
   PubMedGoogle Scholar
• Jin Y, Wu Z, Wu C, et al. Size-adaptable and ligand (biotin)-sheddable nanocarriers equipped with avidin scavenging technology for deep tumor penetration and reduced toxicity. J Control Release. 2020;320:142–158. doi:10.1016/j.jconrel.2020.01.040
   PubMed Web of Science ®Google Scholar
• Tan H, Song Y, Chen J, et al. Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2021;8(15):e2100787. doi:10.1002/advs.202100787
   PubMedGoogle Scholar
• Xia Q, Zhang Y, Li Z, Hou X, Feng N. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B. 2019;9(4):675–689. doi:10.1016/j.apsb.2019.01.011
   PubMed Web of Science ®Google Scholar
• Yang R, Xu J, Xu L, et al. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination. ACS Nano. 2018;12(6):5121–5129. doi:10.1021/acsnano.7b09041
   PubMed Web of Science ®Google Scholar
• Kang T, Zhu Q, Wei D, et al. Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis. ACS Nano. 2017;11(2):1397–1411. doi:10.1021/acsnano.6b06477
   PubMed Web of Science ®Google Scholar
• Choi Y, Bowman JW, Jung JU. Autophagy during viral infection - a double-edged sword. Nat Rev Microbiol. 2018;16(6):341–354. doi:10.1038/s41579-018-0003-6
   PubMed Web of Science ®Google Scholar
• Russo M, Russo GL. Autophagy inducers in cancer. Biochem Pharmacol. 2018;153:51–61. doi:10.1016/j.bcp.2018.02.007
   PubMed Web of Science ®Google Scholar
• Xi G, Hu X, Wu B, et al. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett. 2011;307(2):141–148. doi:10.1016/j.canlet.2011.03.026
   PubMed Web of Science ®Google Scholar
• Long X, Wang H, Yan J, et al. Tailor-Made Autophagy Cascade Amplification Polymeric Nanoparticles for Enhanced Tumor Immunotherapy. Small. 2023;19(24):e2207898. doi:10.1002/smll.202207898
   PubMed Web of Science ®Google Scholar
• Kinsey CG, Camolotto SA, Boespflug AM, et al. Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med. 2019;25(4):620–627. doi:10.1038/s41591-019-0367-9
   PubMed Web of Science ®Google Scholar
• Chengli Y, Zhipneg W, Ming L, Zhichang Z. Pilot Study on the Preparation of EVO-CQ-Lips and Its Anti-cancer Effect on Breast Cancer. J Cancer Control Treatment. 2022;35(02):93–101.
   Google Scholar
• Solanki R, Jangid AK, Jadav M, Kulhari H, Patel S. Folate Functionalized and Evodiamine-Loaded Pluronic Nanomicelles for Augmented Cervical Cancer Cell Killing. Macromol Biosci. 2023;23(9):e2300077. doi:10.1002/mabi.202300077
   PubMed Web of Science ®Google Scholar
• Tan X, Zhou Y, Shen L, Jia H, Tan X. A mitochondria-targeted delivery system of doxorubicin and evodiamine for the treatment of metastatic breast cancer. RSC Adv. 2019;9(63):37067–37078. doi:10.1039/c9ra07096f
   PubMed Web of Science ®Google Scholar
• Zhao X, He S, Li B, et al. DUCNP@Mn-MOF/FOE as a Highly Selective and Bioavailable Drug Delivery System for Synergistic Combination Cancer Therapy. Nano Lett. 2023;23(3):863–871. doi:10.1021/acs.nanolett.2c04042
   PubMed Web of Science ®Google Scholar
• Li C, Cai G, Song D, et al. Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer. Biomater Sci. 2019;7(9):3627–3639. doi:10.1039/c9bm00613c
   PubMed Web of Science ®Google Scholar
• Run-tian G, Rong-rong Z, Ni Y, Xiao-na R, Shi-ying L. Icartin and pyropheophorbide-a self-assembled nanomedicine for enchanced the efficacy of photodynamic tumour therapy by increase the cell autophagy. Acta Pharm Sin. 2023;58(08):2483–2493. doi:10.16438/j.0513-4870.2022-0997
   Google Scholar
• Ji Y, Zhang Z, Hou W, et al. Enhanced antitumor effect of icariin nanoparticles coated with iRGD functionalized erythrocyte membrane. Eur J Pharmacol. 2022;931:175225. doi:10.1016/j.ejphar.2022.175225
   PubMed Web of Science ®Google Scholar
• Wang S, Wuniqiemu T, Tang W, et al. Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex. Int Immunopharmacol. 2021;94:107460. doi:10.1016/j.intimp.2021.107460
   PubMed Web of Science ®Google Scholar
• Fu QT, Zhong XQ, Chen MY, et al. Luteolin-Loaded Nanoparticles for the Treatment of Melanoma. Int J Nanomed. 2023;18:2053–2068. doi:10.2147/ijn.S400329
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Q, Feng W, et al. Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment. Drug Deliv. 2021;28(1):1695–1708. doi:10.1080/10717544.2021.1963351
   PubMed Web of Science ®Google Scholar
• Backe SJ, Sager RA, Heritz JA, et al. Activation of autophagy depends on Atg1/Ulk1-mediated phosphorylation and inhibition of the Hsp90 chaperone machinery. Cell Rep. 2023;42(7):112807. doi:10.1016/j.celrep.2023.112807
   PubMed Web of Science ®Google Scholar
• Humbert M, Seiler K, Mosimann S, et al. Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy. Cell Death Differ. 2021;28(8):2465–2481. doi:10.1038/s41418-021-00768-1
   PubMed Web of Science ®Google Scholar
• Fan R, Chen C, Mu M, et al. Engineering MMP-2 Activated Nanoparticles Carrying B7-H3 Bispecific Antibodies for Ferroptosis-Enhanced Glioblastoma Immunotherapy. ACS Nano. 2023;17(10):9126–9139. doi:10.1021/acsnano.2c12217
   PubMed Web of Science ®Google Scholar
• Yang G, Song T, Zhang H, et al. Stimulus-Detonated Biomimetic “Nanobomb” with Controlled Release of HSP90 Inhibitor to Disrupt Mitochondrial Function for Synergistic Gas and Photothermal Therapy. Adv Healthc Mater. 2023;12(26):e2300945. doi:10.1002/adhm.202300945
   PubMed Web of Science ®Google Scholar
• Wu P, Zhang H, Yin Y, et al. Engineered EGCG-Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy. Adv Sci (Weinh). 2022;9(15):e2105894. doi:10.1002/advs.202105894
   PubMedGoogle Scholar
• Granja A, Neves AR, Sousa CT, Pinheiro M, Reis S. EGCG intestinal absorption and oral bioavailability enhancement using folic acid-functionalized nanostructured lipid carriers. Heliyon. 2019;5(7):e02020. doi:10.1016/j.heliyon.2019.e02020
   PubMed Web of Science ®Google Scholar
• Sudha T, Salaheldin TA, Darwish NH, Mousa SA. Antitumor/anti-angiogenesis efficacy of epigallocatechin gallate nanoformulated with antioxidant in melanoma. Nanomedicine. 2022;17(15):1039–1053. doi:10.2217/nnm-2021-0362
   PubMed Web of Science ®Google Scholar
• Yang S, Gao X, He Y, et al. Applying an innovative biodegradable self-assembly nanomicelles to deliver α-mangostin for improving anti-melanoma activity. Cell Death Dis. 2019;10(3):146. doi:10.1038/s41419-019-1323-9
   PubMedGoogle Scholar
• Feng J, Xu M, Wang J, et al. Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer. Biomaterials. 2020;241:119907. doi:10.1016/j.biomaterials.2020.119907
   PubMed Web of Science ®Google Scholar
• Bonafè F, Pazzini C, Marchionni S, Guarnieri C, Muscari C. Complete Disaggregation of MCF-7-derived Breast Tumour Spheroids with Very Low Concentrations of α-Mangostin Loaded in CD44 Thioaptamer-tagged Nanoparticles. Int J Med Sci. 2019;16(1):33–42. doi:10.7150/ijms.28135
   PubMed Web of Science ®Google Scholar
• Doan VTH, Takano S, Doan NAT, et al. Anticancer efficacy of cyclodextrin-based hyperbranched polymer nanoparticles containing alpha-mangostin. Polym J. 2021;53:481–492. doi:10.1038/s41428-020-00441-3
   Web of Science ®Google Scholar
• Pham DT, Saelim N, Tiyaboonchai W. Alpha mangostin loaded crosslinked silk fibroin-based nanoparticles for cancer chemotherapy. Colloids Surf B Biointerfaces. 2019;181:705–713. doi:10.1016/j.colsurfb.2019.06.011
   PubMed Web of Science ®Google Scholar
• Shi W, Feng W, Li S, et al. Ferroptosis and Necroptosis Produced Autologous Tumor Cell Lysates Co-Delivering with Combined Immnoadjuvants as Personalized In Situ Nanovaccines for Antitumor Immunity. ACS Nano. 2023;17(15):14475–14493. doi:10.1021/acsnano.3c00901
   PubMed Web of Science ®Google Scholar
• Wang H, Tang Y, Fang Y, et al. Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1. Nano Lett. 2019;19(5):2935–2944. doi:10.1021/acs.nanolett.9b00021
   PubMed Web of Science ®Google Scholar
• Muniraj N, Siddharth S, Shriver M, et al. Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment. Cell Death Discov. 2020;6:81. doi:10.1038/s41420-020-00315-w
   PubMed Web of Science ®Google Scholar
• Wang J, Liu D, Guan S, et al. Hyaluronic acid-modified liposomal honokiol nanocarrier: enhance anti-metastasis and antitumor efficacy against breast cancer. Carbohydr Polym. 2020;235:115981. doi:10.1016/j.carbpol.2020.115981
   PubMed Web of Science ®Google Scholar
• Wang J, Yang H, Li Q, et al. Novel nanomicelles based on rebaudioside A: a potential nanoplatform for oral delivery of honokiol with enhanced oral bioavailability and antitumor activity. Int J Pharm. 2020;590:119899. doi:10.1016/j.ijpharm.2020.119899
   PubMed Web of Science ®Google Scholar
• Tang P, Sun Q, Yang H, Tang B, Pu H, Li H. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer. Int J Pharm. 2018;545(1–2):74–83. doi:10.1016/j.ijpharm.2018.04.060
   PubMedGoogle Scholar
• Xing-xing S, Le S, Liang-yu Y, Yu-zhen N, Tao L. Effect of Evodiamine Combined with Chloroquine on Hepatocarcinoma. Acta Univ Med Nanjing. 2021;37(03):400–403. doi:10.14148/j.issn.1672-0482.2021.0400
   Google Scholar
• Yamaguchi J, Yokoyama Y, Fujii T, et al. Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01). Ann Surg. 2022;275(6):1043–1049. doi:10.1097/sla.0000000000005430
   PubMed Web of Science ®Google Scholar
• Lin YW, Lin TT, Chen CH, et al. Enhancing Efficacy of Albumin-Bound Paclitaxel for Human Lung and Colorectal Cancers through Autophagy Receptor Sequestosome 1 (SQSTM1)/p62-Mediated Nanodrug Delivery and Cancer therapy. ACS Nano. 2023;17(19):19033–19051. doi:10.1021/acsnano.3c04739
   PubMed Web of Science ®Google Scholar
• Batra H, Pawar S, Bahl D. Curcumin in combination with anti-cancer drugs: a nanomedicine review. Pharmacol Res. 2019;139:91–105. doi:10.1016/j.phrs.2018.11.005
   PubMed Web of Science ®Google Scholar
• Ratan C, Arian AM, Rajendran R, Jayakumar R, Masson M, Mangalathillam S. Nano-based formulations of curcumin: elucidating the potential benefits and future prospects in skin cancer. Biomed Mater. 2023;18(5):548. doi:10.1088/1748-605X/acf0af
   Web of Science ®Google Scholar
• Hanafy NAN, Sheashaa RF, Moussa EA, Mahfouz ME. Potential of curcumin and niacin-loaded targeted chitosan coated liposomes to activate autophagy in hepatocellular carcinoma cells: an in vitro evaluation in HePG2 cell line. Int J Biol Macromol. 2023;245:125572. doi:10.1016/j.ijbiomac.2023.125572
   PubMed Web of Science ®Google Scholar
• Zhang X, Gao H, Wei D, et al. ROS Responsive Nanoparticles Encapsulated with Natural Medicine Remodel Autophagy Homeostasis in Breast Cancer. ACS Appl Mater Interfaces. 2023;15(25):29827–29840. doi:10.1021/acsami.3c03068
   PubMed Web of Science ®Google Scholar
• Bamburowicz-Klimkowska M, Poplawska M, Grudzinski IP. Nanocomposites as biomolecules delivery agents in nanomedicine. J Nanobiotechnology. 2019;17(1):48. doi:10.1186/s12951-019-0479-x
   PubMedGoogle Scholar
• Mei Y, Qin X, Yang Z, et al. Engineered a dual-targeting HA-TPP/A nanoparticle for combination therapy against KRAS-TP53 co-mutation in gastrointestinal cancers. Bioact Mater. 2024;32:277–291. doi:10.1016/j.bioactmat.2023.10.003
   PubMed Web of Science ®Google Scholar
• Sun X, Chen H, Gao R, et al. Intravenous Transplantation of an Ischemic-specific Peptide-TPP-mitochondrial Compound Alleviates Myocardial Ischemic Reperfusion Injury. ACS Nano. 2023;17(2):896–909. doi:10.1021/acsnano.2c05286
   PubMedGoogle Scholar
• Feng Y, Liao Z, Li M, et al. Mesoporous Silica Nanoparticles-Based Nanoplatforms: basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics. Adv Healthc Mater. 2023;12(16):e2201884. doi:10.1002/adhm.202201884
   PubMed Web of Science ®Google Scholar
• Mabrouk M, Das DB, Salem ZA, Beherei HH. Nanomaterials for Biomedical Applications: production, Characterisations, Recent Trends and Difficulties. Molecules. 2021;26(4):1077. doi:10.3390/molecules26041077
   PubMed Web of Science ®Google Scholar
• Liu J, Shi J, Nie W, Wang S, Liu G, Cai K. Recent Progress in the Development of Multifunctional Nanoplatform for Precise Tumor Phototherapy. Adv Healthc Mater. 2021;10(1):e2001207. doi:10.1002/adhm.202001207
   PubMed Web of Science ®Google Scholar
• Zhu M, Zhuang J, Li Z, et al. Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures. Nat Nanotechnol. 2023;18(6):657–666. doi:10.1038/s41565-023-01323-4
   PubMed Web of Science ®Google Scholar
• Zaslavsky J, Bannigan P, Allen C. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence. Expert Opin Drug Deliv. 2023;20(2):241–257. doi:10.1080/17425247.2023.2167978
   PubMed Web of Science ®Google Scholar
• Bannigan P, Aldeghi M, Bao Z, Häse F, Aspuru-Guzik A, Allen C. Machine learning directed drug formulation development. Adv Drug Deliv Rev. 2021;175:113806. doi:10.1016/j.addr.2021.05.016
   PubMed Web of Science ®Google Scholar
• Issa NT, Stathias V, Schürer S, Dakshanamurthy S. Machine and deep learning approaches for cancer drug repurposing. Semin Cancer Biol. 2021;68:132–142. doi:10.1016/j.semcancer.2019.12.011
   PubMed Web of Science ®Google Scholar
• Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics. 2023;15(7):1916. doi:10.3390/pharmaceutics15071916
   PubMed Web of Science ®Google Scholar
• Ding J, Wang C, Sun Y, Guo J, Liu S, Cheng Z. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer. Biomolecules. 2023;13(2):339. doi:10.3390/biom13020339
   PubMed Web of Science ®Google Scholar
• Badwan BA, Liaropoulos G, Kyrodimos E, Skaltsas D, Tsirigos A, Gorgoulis VG. Machine learning approaches to predict drug efficacy and toxicity in oncology. Cell Rep Methods. 2023;3(2):100413. doi:10.1016/j.crmeth.2023.100413
   PubMedGoogle Scholar